Phase 2 Estrogen-receptor-positive Breast Cancer trials recruiting now

All Estrogen-receptor-positive Breast Cancer trials, every phase

Phase 2 Estrogen-receptor-positive Breast Cancer trials

• Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
  NCT06525766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
  NCT06062498 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
  NCT07340541 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)
  NCT06150898 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
  NCT07222215 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.